Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    21169471 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
Condition: Cystic Fibrosis
Interventions: Drug: denufosol tetrasodium (INS37217) Inhalation Solution;   Drug: Placebo - 0.9% w/v sodium chloride solution
To Top

† Indicates status has not been verified in more than two years